SIEMENS HEALTHINEESIEMENS HEALTHINEESIEMENS HEALTHINEE

SIEMENS HEALTHINEE

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪54.38 B‬CHF
1.639CHF
‪1.83 B‬CHF
‪21.10 B‬CHF
‪263.73 M‬
Beta (1Y)
1.15
Employees (FY)
‪72 K‬
Change (1Y)
‪+1 K‬ +1.41%
Revenue / Employee (1Y)
‪293.06 K‬CHF
Net income / Employee (1Y)
‪25.45 K‬CHF

About SIEMENS HEALTHINEERS AG


CEO
Bernhard Montag
Headquarters
Forchheim
Founded
2017
ISIN
DE000SHL1006
FIGI
BBG00KB2QLK1
Siemens Healthineers AG is a holding company that provides healthcare equipment, solutions, and services globally. It operates through the following business segments: Imaging, Diagnotics, Varian and Advanced Therapies. The Imaging segment provides imaging products, services, and solutions as well as digital offerings. The Diagnostics segment provides a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Varian segment provides innovative, multi-modality cancer care technologies based on integrated, advanced imaging, along with solutions and services to oncology departments in hospitals and clinics globally. The Advanced Therapies segment consist of integrated products, services and solutions across multiple clinical fields used in the treatment of diseases. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Forchheim, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SHL is 50.147 CHF — it has decreased by −0.14% in the past 24 hours. Watch SIEMENS HEALTHINEE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange SIEMENS HEALTHINEE stocks are traded under the ticker SHL.
SHL stock has fallen by −0.14% compared to the previous week, the month change is a 8.26% rise, over the last year SIEMENS HEALTHINEE has showed a 0.14% increase.
We've gathered analysts' opinions on SIEMENS HEALTHINEE future price: according to them, SHL price has a max estimate of 61.48 CHF and a min estimate of 45.65 CHF. Watch SHL chart and read a more detailed SIEMENS HEALTHINEE stock forecast: see what analysts think of SIEMENS HEALTHINEE and suggest that you do with its stocks.
SHL reached its all-time high on Nov 18, 2021 with the price of 69.469 CHF, and its all-time low was 39.607 CHF and was reached on Sep 29, 2022. View more price dynamics on SHL chart.
See other stocks reaching their highest and lowest prices.
SHL stock is 0.14% volatile and has beta coefficient of 1.15. Track SIEMENS HEALTHINEE stock price on the chart and check out the list of the most volatile stocks — is SIEMENS HEALTHINEE there?
Today SIEMENS HEALTHINEE has the market capitalization of ‪54.63 B‬, it has decreased by −0.56% over the last week.
Yes, you can track SIEMENS HEALTHINEE financials in yearly and quarterly reports right on TradingView.
SIEMENS HEALTHINEE is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
SHL earnings for the last quarter are 0.63 CHF per share, whereas the estimation was 0.60 CHF resulting in a 4.50% surprise. The estimated earnings for the next quarter are 0.44 CHF per share. See more details about SIEMENS HEALTHINEE earnings.
SIEMENS HEALTHINEE revenue for the last quarter amounts to ‪5.97 B‬ CHF, despite the estimated figure of ‪5.96 B‬ CHF. In the next quarter, revenue is expected to reach ‪4.87 B‬ CHF.
SHL net income for the last quarter is ‪582.16 M‬ CHF, while the quarter before that showed ‪450.67 M‬ CHF of net income which accounts for 29.18% change. Track more SIEMENS HEALTHINEE financial stats to get the full picture.
Yes, SHL dividends are paid annually. The last dividend per share was 0.92 CHF. As of today, Dividend Yield (TTM)% is 1.82%. Tracking SIEMENS HEALTHINEE dividends might help you take more informed decisions.
SIEMENS HEALTHINEE dividend yield was 1.76% in 2024, and payout ratio reached 54.70%. The year before the numbers were 1.98% and 70.47% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has ‪72.00 K‬ employees. See our rating of the largest employees — is SIEMENS HEALTHINEE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SIEMENS HEALTHINEE EBITDA is ‪4.35 B‬ CHF, and current EBITDA margin is 20.23%. See more stats in SIEMENS HEALTHINEE financial statements.
Like other stocks, SHL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SIEMENS HEALTHINEE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SIEMENS HEALTHINEE technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SIEMENS HEALTHINEE stock shows the neutral signal. See more of SIEMENS HEALTHINEE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.